New patent expiration for Bristol Myers drug ZERIT XR

Copyright © DrugPatentWatch. Originally published at https://www.drugpatentwatch.com/blog/

Annual Drug Patent Expirations for ZERIT+XR
Annual Drug Patent Expirations for ZERIT+XR

Zerit Xr is a drug marketed by Bristol Myers Squibb and is included in one NDA. There is one patent protecting this drug.

The generic ingredient in ZERIT XR is stavudine. Additional details are available on the stavudine profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

» Start Your Free Trial Today «

Copyright © DrugPatentWatch. Originally published at
DrugPatentWatch - Make Better Decisions
Scroll to Top